Time-dependent benefits of pre-treatment with new oral P2Y [electronic resource]
Producer: 20200414Description: 592-601 p. digitalISSN:- 1522-726X
- Administration, Oral
- Aged
- Blood Platelets -- drug effects
- Coronary Angiography
- Drug Administration Schedule
- Female
- Humans
- Male
- Middle Aged
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Prasugrel Hydrochloride -- administration & dosage
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Receptors, Purinergic P2Y12 -- blood
- Risk Assessment
- Risk Factors
- ST Elevation Myocardial Infarction -- diagnostic imaging
- Ticagrelor -- administration & dosage
- Time Factors
- Time-to-Treatment
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.